Free Trial
NASDAQ:PPH

VanEck Pharmaceutical ETF (PPH) Price, Holdings, & News

VanEck Pharmaceutical ETF logo
$88.95 -2.18 (-2.39%)
As of 02:09 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About VanEck Pharmaceutical ETF (NASDAQ:PPH)

Key Stats

Today's Range
$89.28
$90.31
50-Day Range
$85.88
$94.86
52-Week Range
$84.48
$99.51
Volume
28,886 shs
Average Volume
285,415 shs
Market Capitalization
$555.04 million
Assets Under Management
$668.74 million
Dividend Yield
1.91%
Net Expense Ratio
0.36%
Aggregate Rating
Moderate Buy

ETF Overview

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Remove Ads

VanEck Pharmaceutical ETF Expenses

TypePPHHealth Care ETFsEquity ETFsNASDAQ ETFsAll ETFs
Management Fee0.35%0.57%0.56%0.53%0.53%
Other Expenses0.01%0.30%0.49%0.43%0.52%
Total Expense0.36%0.70%0.72%0.68%0.71%
Fee Waiver0.00%-0.45%-0.50%-0.30%-0.55%
Net Expense0.36%0.61%0.63%0.61%0.60%
Receive PPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for VanEck Pharmaceutical ETF and its competitors with MarketBeat's FREE daily newsletter.

PPH ETF News Headlines

Now I look stupid. Real stupid...
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Diversified Exposure To The Weight Loss Drug Market
See More Headlines

PPH ETF - Frequently Asked Questions

VanEck Pharmaceutical ETF's stock was trading at $86.28 at the start of the year. Since then, PPH shares have increased by 3.7% and is now trading at $89.4760.
View the best growth stocks for 2025 here
.

Shares of PPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that VanEck Pharmaceutical ETF investors own include Waste Connections (WCN), iShares Micro-Cap ETF (IWC), The RMR Group (RMR), DiamondRock Hospitality (DRH), AUO (AUOTY), American Water Works (AWK) and Triple Flag Precious Metals (TFPM).

Fund Details

Issuer
Van Eck
Fund Name
VanEck Pharmaceutical ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NASDAQ
Current Symbol
NASDAQ:PPH
Inception Date
12/20/2011
Fund Manager
Hao-Hung Peter Liao, Guo Hua Jason Jin
Web
N/A

Fund Focus

Asset Class
Equity
Benchmark
Market Vectors US Listed Pharmaceutical 25 Index
Category
Sector
Focus
Health Care
Development Level
Developed Markets
Region
Global
Number of Holdings
26

Fund Statistics

Assets Under Management
$668.74 million
Average Daily Volume
$192,316.40
Discount/Premium
0.00%

Administrator, Advisor and Custodian

Administrator
Van Eck Associates Corporation
Advisor
Van Eck Associates Corporation
Custodian
State Street Bank and Trust Company
Distributor
Van Eck Securities Corporation
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
IMC

Options

Optionable
Optionable
Options Volume
17
Put Options
7
Call Options
10
Short Interest
2,570,000 shs

Miscellaneous

Beta
0.72
Creation Unit
50,000
Creation Fee
$500.00
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

Top 10 PPH Holdings


This page (NASDAQ:PPH) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners